Jubilant Ingrevia reports earnings for Q3FY22

The Board of Jubilant Ingrevia Limited met today to approve financial results for the quarter & Nine Months ended December 31st, 2021. The Board also declared an interim dividend of Rs 2.5 per equity share of Rs 1 each on the paid up capital of the company.

Q3FY22 Consolidated Financial Highlights

• Revenue grew by 44% on YoY basis, driven by growth across product segments.
• Revenue from Pharma, Nutrition and Agro end use increased significantly.
• Speciality Chemicals revenue grew by 22% YoY driven by volume growth across products and passing-on of higher input costs.
• Nutrition and Health Solutions revenue grew by 37% YoY driven by higher volumes and improved price realisation.
• Life Sciences Chemical revenue grew by 60% YoY, driven by higher prices on account of favorable market conditions.
• EBITDA at Rs 222 Crore, grew by 42%, on account of strong performance of all three product segments.
• PAT grew by 42% YoY driven by growth in EBITDA, added by reduction in finance cost through reduction in Gross debt and optimization of Interest rates.
• ROCE in 9M'FY22 improved to 31.1% as against 20.2% in FY21.
• ROE in 9M'FY22 stood at 25.2% as against 16.4% in FY21.

Commenting on the Company's performance, Mr. Shyam S Bhartia, Chairman and Mr. Hari S Bhartia, CoChairman, Jubilant Ingrevia Limited said: "We are pleased to announce that in Q3'FY22 we continued to witness significant growth in our Revenue & EBITDA. We are also delighted to declared an interim dividend of Rs. 2.5 per equity share of Rs 1 each of the company amounting to Rs 39.8 Cr.

In our Specialty Chemicals segment we maintained strong growth across the products led by growing demand from Pharmaceutical, and Nutrition customers. In Nutrition & Health Solution the demand of Vitamin B3 improved and we placed higher volumes with improved realizations. In Life Science Chemical Segment, we continued the strong performance with healthy demand in domestic as well as in EU market.

Our business team worked closely with customers and ensured that most of the increase in input cost is passed on and our supply chain team ensured the uninterrupted supplies and timely deliveries.

We are pleased to inform, that in DJSI (Dow Jones Sustainability Index) Environmental Social & Governance (ESG) assessment, we scored 81 percentile in the global chemical industry and have been ranked among the top 20% chemical companies globally and amongst the Top 3 chemical companies in India.

We remain excited with the growth opportunities in our businesses and are fully committed to realize them. Our strong new product pipeline developed by our in-house R&D, our technical expertise into various chemistry platforms and long-standing relationship with global Pharmaceutical & Agrochemical customers is a strong enabler in our growth journey . With our growth capex plans shaping up we remain in course of doubling the revenue by FY'26 from the base of FY'21."

Shares of Jubilant Ingrevia Limited was last trading in BSE at Rs. 572.25 as compared to the previous close of Rs. 552.65. The total number of shares traded during the day was 46217 in over 2070 trades.

The stock hit an intraday high of Rs. 578.95 and intraday low of 556.00. The net turnover during the day was Rs. 26271602.00.

Source : Equity Bulls

Keywords

JubilantIngrevia INE0BY001018 JUBLINGREA SpecialtyChemicals Q3FY22 9MFY22 ResultUpdate